Editorial in response to the systematic review by de Vos et al: 'Strong evidence against platelet-rich plasma injections for chronic lateral epicondylar tendinopathy: A systematic review'

摘要

We would like to compliment the authors on their recent efforts to construct a review article concerning the use of platelet-rich plasma (PRP) in the treatment of lateral epicondylar tendinopathy. As the authors of two of the studies evaluated in the paper, we would like to comment about the interpretation of our investigations and provide suggestions about the conclusions that may be drawn from the published data.